Navigation Links
VIVUS Resubmits Qnexa NDA to the FDA
Date:10/17/2011

eep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate" and "intend," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the acceptability of our response to the FDA's requests stemming from the End of Review meeting; our response to, and continued dialogue with, the FDA relating to matters raised in the FDA's CRL; the timing and results of the retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy; the FDA's interpretation of and agreement with the information VIVUS submitted and may submit relating to teratogenicity and cardiovascular safety; the FDA's interpretation of the data from our SEQUEL study, or OB-305; the FDA's requests, if any, to conduct additional prospective studies or retrospective observational studies or to provide further analysis of clinical trial data; the review and questions from the EMA and CHMP on the MAA; substantial competition; the impact on future sales based on specific indications and contraindications contained in the label and the extent of the Risk Evaluation and Mitigation Strategies program; uncertainties of litigation and intellectual property and patent protection; reliance on sole-source suppliers; limited sales and marketing resources and dependence upon third parties; risks related to the development of innovative products; risks related to the
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
3. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
4. VIVUS Announces Promotion of Peter Tam to President
5. VIVUS to Present at Lazard Capital Markets Healthcare Conference
6. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
7. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
8. VIVUS Announces Sale of MUSE Assets to Meda
9. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)...  Eli Lilly and Company (NYSE: LLY ) announced ... for up to $1.6 billion aggregate principal amount (the "tender ... billion in aggregate principal amount of the notes listed in ... on or prior to 5:00 p.m., New York ... tender date for the offer. The table ...
(Date:5/27/2015)... , May 27, 2015 ... announced the addition of the  "2015 Strategies ...  report to their offering. ... pertaining to the UK NAT laboratory practice, ... social and technological trends with significant market ...
(Date:5/27/2015)... 2015 Research and ... of the  "North America Mammography Market - ...  report to their offering. ... a detailed type of imaging that customs ... A mammography exam, called a mammogram, is ...
Breaking Medicine Technology:Lilly Announces the Early Results of Its Cash Tender Offer 2Lilly Announces the Early Results of Its Cash Tender Offer 3Lilly Announces the Early Results of Its Cash Tender Offer 4Lilly Announces the Early Results of Its Cash Tender Offer 5North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2
(Date:5/28/2015)... (PRWEB) May 28, 2015 First ... freestanding emergency rooms in the United States, announced that ... new Denver – Green Valley Ranch facility. , ... increased access to the highest quality emergency medical care ... Valley Ranch facility,” said Dr. James M. Muzzarelli, Executive ...
(Date:5/28/2015)... SpendWell Health, an e-commerce marketplace for ... named a “Cool Vendor” by Gartner in the April ... Payers, 2015 by Jeff Cribbs, Constance Sjoquist, Robert ... vendors, products and services in health care technology—which serve ... care payer market. , SpendWell’s solution delivers the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Peggy J. Lynam, ... Delegate to the American Physical Therapy Association House of Delegates ... Delegation at their Delegate Assembly. This will be her ... Delegates serves as coordinator and principle spokesperson for the Chapter ... Board of Directors or Delegate Assembly may direct the Chief ...
(Date:5/27/2015)... Riverdale, NJ (PRWEB) May 28, 2015 Throughout ... a study site for research comparing the validity and reliability ... Dr. Preeti Nair, P.T., Ph.D., Associate Professor in the ... principle investigator for the study. , The Shaw Gait Assessment ... $30,000 piece of equipment. The GaitRite is considered the ...
(Date:5/27/2015)... StatRad, a leading provider of cloud-based medical ... Mr. Chris E. Hafey as its new Chief Technology ... of leading new development projects and has extensive experience ... served as the Chief Technology Officer for OnPoint Medical ... for Vital Images. , "I am very excited to ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room to Open New Facility in Denver, Colorado 2Health News:SpendWell Named a “Cool Vendor” by Gartner 2Health News:SpendWell Named a “Cool Vendor” by Gartner 3Health News:SpendWell Named a “Cool Vendor” by Gartner 4Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2
... ... who has been providing an invaluable service to consumers who are overwhelmed with ... a high rating by the BBB (Better Business Bureau).,New York, NY (PRWEB) ... and debt relief company, has become a proud member of the TASC (The ...
... Boston, Mass. About 40 percent of children and up ... leukemia (AML) will have a relapse. In recent years, doctors ... stem cells, endlessly replicating cancer cells that generate the immature ... cancer treatments. Now, researchers at Children,s Hospital Boston have found ...
... ... or capacity for change, in the neural circuitry of the visual cortex of juvenile mice. The ... human brain that would allow for the repair of neural circuits following injury or disease. ... San Francisco, CA (Vocus) March ...
... as lymph nodes, cancer can evade detection, researchers find ... from Switzerland provides insight into how tumors remain undetected ... , "The tumor tricks the body into thinking it ... the Laboratory of Lymphatic and Cancer Bioengineering, said in ...
... This press release is available in French ... have discovered a previously hidden channel to attack leukemia and ... the Journal of Biological Chemistry . The findings from ... change the way doctors treat cancer patients. "We found ...
... ... for cloud hosting technology, 2. What is web hosting, 3. What is cloud server web hosting, ... 6. Where you can get good cloud server web hosting , ... Burlington, VT (PRWEB) March 24, 2010 -- On March 25th 2010 Omega ...
Cached Medicine News:Health News:National Debt Relief Group Celebrates Proud Membership with TASC (The Association for Settlement Companies) 2Health News:Targeting cell pathway may prevent relapse of leukemia 2Health News:Targeting cell pathway may prevent relapse of leukemia 3Health News:New Period of Brain ‘Plasticity' Created with Transplanted Embryonic Cells 2Health News:New Period of Brain ‘Plasticity' Created with Transplanted Embryonic Cells 3Health News:New Period of Brain ‘Plasticity' Created with Transplanted Embryonic Cells 4Health News:New Period of Brain ‘Plasticity' Created with Transplanted Embryonic Cells 5Health News:New gateway to treat leukemia and other cancers 2Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 2Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 3Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 4Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 5Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 6
Inquire...
Supercassette quick release holder for the 8000 Series sliding microtome to allow for the use of wax supercassettes, 75x52x19 mm....
... 5040 microtome is of rotary retracting, self-lubricating design ... cutting arm. Its robust construction makes it accurate ... hinges means that all lateral motion is controlled ... be experienced in other, lesser designs which can ...
Spare fuse set...
Medicine Products: